Last reviewed · How we verify

NCT06584669

Investigation of Krill Oil in Women with Premenstrual Syndrome

Completed NA Last updated 5 September 2024
What this trial tests

NA trial testing Krill oil in Premenstrual Syndrome in 179 participants. Completed in 23 August 2013.

Timeline
23 February 2012
Primary endpoint
11 April 2013
23 August 2013

Quick facts

Lead sponsorAker BioMarine Human Ingredients AS
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment179
Start date23 February 2012
Primary completion11 April 2013
Estimated completion23 August 2013
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Aker BioMarine Human Ingredients AS

Who can join

Adults 20 to 50, female only, with Premenstrual Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study the effects of different dosages and preparations of krill oil in comparison to placebo on symptoms of premenstrual syndrome in healthy, female adults will be assessed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Krill oil

Trials testing the same drug.

Other recruiting trials for Premenstrual Syndrome

Currently open trials in the same condition.

Other Aker BioMarine Human Ingredients AS trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06584669.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing